Physicians and patients may need to become more comfortable with giving up some privacy in exchange for achieving better clinical outcomes, speakers suggested at a Brookings Institution workshop.
Five years from now, the mobile health industry will be much faster-moving and in some ways unrecognizable from today’s field, speakers predicted at a May 22 workshop on mobile technology and health innovation at The Brookings Institution in Washington, D.C.
Workshop moderator Darrell West, vice president and director of governance studies at Brookings, said mHealth is expected to become a...
The FTC is suing to block Edwards Lifesciences' purchase of JenaValve, citing concerns that it would reduce competition and innovation in the heart valve market and negatively impact patient access to vital treatments for aortic regurgitation. Edwards disagrees with the decision.
Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.
A federal court in Illinois ruled against SurModics and BC Holdings' request for FDA documents to support a proposed merger. The FTC has challenged the merger, claiming it threatens competition in hydrophilic device coatings. The ruling may indicate the FTC is likely to succeed.
Former HHS-OIG attorney Rob DeConti emphasized the significance of data analytics and compliance in combating healthcare fraud, urging medical tech companies to adopt robust measures to prevent potential risks.
